Related Experiment Video

Updated: Jul 14, 2026

Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays
07:42

Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays

Published on: September 19, 2018

Queuine mediated inhibition in phosphorylation of tyrosine phosphoproteins in cancer

Chandramani Pathak1, Yogesh K Jaiswal, Manjula Vinayak

  • 1Biochemistry & Molecular Biology Laboratory, Center of Advanced Study in Zoology, Banaras Hindu University, Varanasi, India.

Molecular Biology Reports
|May 22, 2007
PubMed

Insights

Queuine, a modified tRNA base, was investigated for its role in cancer. This study found queuine down-regulates tyrosine phosphoproteins, suggesting its involvement in regulating cell proliferation and mitotic signaling pathways.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cell Biology

Background:

  • Protein phosphorylation/dephosphorylation by kinases and phosphatases regulates cell signaling and proliferation.
  • Receptor tyrosine kinase (RTK) signaling deregulation is linked to malignant transformation.
  • Queuine, a modified tRNA base, is known to down-regulate tyrosine kinase activity.

Purpose of the Study:

  • To investigate queuine's role in inhibiting tyrosine phosphoprotein phosphorylation in lymphoma-bearing mice.
  • To understand queuine's potential as a regulator of mitotic signaling pathways.

Main Methods:

  • Investigated tyrosine phosphoprotein levels in DLAT cancerous mouse liver.
  • Administered queuine treatments to lymphoma-bearing mice.
  • Compared protein phosphorylation levels between treated and control groups.

Main Results:

  • DLAT cancerous mouse liver exhibited elevated cytosolic and membrane-associated tyrosine phosphoproteins compared to normal controls.
  • Queuine treatment significantly down-regulated the levels of tyrosine phosphoproteins.
  • These findings suggest queuine's inhibitory effect on tyrosine phosphorylation.

Conclusions:

  • Queuine plays a role in regulating tyrosine kinase activity and mitotic signaling pathways.
  • Queuine deficiency in cancer tissues may contribute to aberrant signaling.
  • Queuine demonstrates potential as a therapeutic agent targeting aberrant cell proliferation.

More Related Videos

Assessing Cellular Target Engagement by SHP2 (PTPN11) Phosphatase Inhibitors08:45

Assessing Cellular Target Engagement by SHP2 (PTPN11) Phosphatase Inhibitors

Published on: July 17, 2020

Related Concept Videos

Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...